Cargando…

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin

Detalles Bibliográficos
Autores principales:	Kinn, Johan M, Zirakzadeh, Ali, Hu, Jin, Winqvist, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242243/ http://dx.doi.org/10.1186/1479-5876-9-S2-P17

Ejemplares similares

The effect of chemotherapeutic drugs on human B lymphocytes
por: Zirakzadeh, Ali, et al.
Publicado: (2013)

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients
por: Zirakzadeh, A Ali, et al.
Publicado: (2015)

The many flavors of tumor-associated B cells
por: Marits, Per, et al.
Publicado: (2013)

SOCS2 expression in bone marrow derived dendritic cells is a positive regulator of T cell activation
por: Hu, Jin, et al.
Publicado: (2012)

The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes
por: Omsland, M, et al.
Publicado: (2015)

Outcome and non-chemotherapeutic treatment in pleural empyema
por: Nielsen, Jannie, et al.
Publicado: (2009)

Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier
por: Sun, Jing-jing, et al.
Publicado: (2017)

P11-05. Induction of CD8+ T cell mediated immune responses through skin and mucosa: identification of immunostimulatory versus tolerogenic dendritic cells
por: Dubois, B, et al.
Publicado: (2009)

Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
por: Linton, Ludvig, et al.
Publicado: (2012)

IGN004 is an antibody-interferon-alpha fusion protein against a novel tumor-associated antigen with both direct anti-tumor and immunostimulatory effects
por: Steward, Kristopher K, et al.
Publicado: (2015)

RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile
por: Heidenreich, Regina, et al.
Publicado: (2015)

Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in breast cancer cells
por: Shirahata, Sanetaka, et al.
Publicado: (2013)

Cardiac MRI for the assessment of early chemotherapeutic cardiac injury and toxicity
por: Franklin, Bina, et al.
Publicado: (2015)

Immune-Activated B Cells Are Dominant in Prostate Cancer
por: Saudi, Aws, et al.
Publicado: (2023)

Synergistic antitumor activity of the CD122-biased immunostimulatory cytokine NKTR-214 when combined with anti-PD-1 in murine tumor models
por: Murali, Addepalli, et al.
Publicado: (2015)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen- a randomized controlled trial
por: Hellkvist, Laila, et al.
Publicado: (2015)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin
por: Ohana, Joel, et al.
Publicado: (2023)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Interface of post-translational glycosylation and endoplasmic reticulum stress in melanoma: target to cancer cell sensitization to chemotherapeutic agents?
por: Lourenço, Luiza HM, et al.
Publicado: (2013)

Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
por: Lu, Chuanwen, et al.
Publicado: (2012)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
por: Pang, Baoxu, et al.
Publicado: (2013)

Citrullination of fibrinogen: generation of neoepitopes and enhancement of immunostimulatory properties
por: Robinson, William H, et al.
Publicado: (2012)

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid
por: Lefley, DV, et al.
Publicado: (2008)

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
por: Wu, Debra, et al.
Publicado: (2020)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

Long Lasting Local and Systemic Inflammation after Cerebral Hypoxic ischemia in Newborn Mice
por: Winerdal, Max, et al.
Publicado: (2012)

Doxorubicin leads to impaired insulin signaling in skeletal muscle
por: Alves de Lima, Edson, et al.
Publicado: (2014)

Adipose tissue homeostasis is deeply disrupted by doxorubicin treatment
por: Batatinha, Helena, et al.
Publicado: (2014)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer
por: Zhang, Lu, et al.
Publicado: (2021)

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release
por: Ijäs, Heini, et al.
Publicado: (2021)

Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer
por: Zhang, Lu, et al.
Publicado: (2018)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

Chemotherapeutics for vivax malaria
por: Baird, J Kevin
Publicado: (2012)

Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin
por: Swietach, Pawel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h44qd3q4317t7ibtsga4p85kpb